These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 22594897
1. Pathogenesis and management of primary CNS lymphoma. Roth P, Korfel A, Martus P, Weller M. Expert Rev Anticancer Ther; 2012 May; 12(5):623-33. PubMed ID: 22594897 [Abstract] [Full Text] [Related]
2. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma. Cheng T, Forsyth P, Chaudhry A, Morris D, Glück S, Russell JA, Stewart DA. Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608 [Abstract] [Full Text] [Related]
3. [Management of primary central nervous system lymphoma]. Gonzalez-Aguilar A, Houillier C, Soussain C, Hoang-Xuan K. Rev Neurol (Paris); 2011 Oct; 167(10):721-8. PubMed ID: 21906768 [Abstract] [Full Text] [Related]
4. Primary CNS lymphoma in immunocompetent patients. Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K. Oncologist; 2009 May; 14(5):526-39. PubMed ID: 19433528 [Abstract] [Full Text] [Related]
5. [Primary central nervous system lymphoma--a report of 32 cases with literature review]. Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ. Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684 [Abstract] [Full Text] [Related]
6. Treatment options for central nervous system lymphomas in immunocompetent patients. Jahnke K, Thiel E. Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839 [Abstract] [Full Text] [Related]
10. Primary central nervous system (CNS) lymphoma in immunocompetent patients. Plasswilm L, Herrlinger U, Korfel A, Weller M, Küker W, Kanz L, Thiel E, Bamberg M. Ann Hematol; 2002 Aug; 81(8):415-23. PubMed ID: 12223997 [Abstract] [Full Text] [Related]
12. Mobilization of hemopoietic stem cells with high-dose methotrexate plus granulocyte-colony-stimulating factor in patients with primary central nervous system lymphoma. Kiefer T, Krüger WH, Montemurro M, Schüler F, Hirt C, Pasold R, Niederwieser D, Schwenke M, Dölken G. Transfusion; 2008 Dec; 48(12):2624-8. PubMed ID: 18801020 [Abstract] [Full Text] [Related]
14. Current management of primary central nervous system lymphoma. Schultz CJ, Bovi J. Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):666-78. PubMed ID: 20159361 [Abstract] [Full Text] [Related]
17. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. Ferreri AJ, Dell'Oro S, Capello D, Ponzoni M, Iuzzolino P, Rossi D, Pasini F, Ambrosetti A, Orvieto E, Ferrarese F, Arrigoni G, Foppoli M, Reni M, Gaidano G. Br J Haematol; 2004 Sep 01; 126(5):657-64. PubMed ID: 15327516 [Abstract] [Full Text] [Related]